Dual Control Fat Burn Pen

Understanding Tirz:
This product is a reusable pen system, which uses refill cartridges for precise and convenient delivery.

Product Strength: 30mg per 3ml cartridge.

Storage: Keep refrigerated between 2–8 °C (36–46 °F) to maintain potency and stability.

What It Is
Tirzepatide is a once-weekly injectable prescription medication that represents a breakthrough in metabolic health. It is the first and only dual GIP and GLP-1 receptor agonist, designed to address two critical natural hormones that regulate blood sugar and appetite. It is marketed as Zepbound for chronic weight management and Mounjaro for type 2 diabetes.

How It Works
Unlike single-hormone agonists, tirzepatide’s dual-action mechanism targets the body’s innate systems to drive results:

GLP-1 Receptor Agonism: Signals the brain to feel full (satiety) and slows gastric emptying, helping you feel fuller for longer.

GIP Receptor Agonism: Enhances the body’s ability to break down fat and improves insulin sensitivity, complementing the weight-loss effects.

Key Benefits for Weight Loss & Metabolic Health
Clinical trials, including the landmark SURMOUNT and SURMOUNT-5 studies, have demonstrated the superior efficacy of tirzepatide:

Substantial Weight Reduction: Patients achieved significant results after 72 weeks. At the maximum maintenance dose of 15 mg, participants lost an average of 23.6 kg (52.0 lb) . Some trials reported total body weight reductions of 20–26.6% when combined with diet and exercise, outperforming single-agonist medications in head-to-head trials.

Appetite Suppression: By activating GLP-1 receptors in the brain and slowing gastric emptying, tirzepatide significantly reduces hunger and lowers calorie intake.

Improved Metabolic Health: Beyond the scale, tirzepatide enhances insulin sensitivity, stabilizes blood sugar, and reduces key risk factors such as waist circumference, blood pressure, and lipid levels, contributing to overall cardiovascular health.

Sustained Long-Term Results: Long-term data (3-year outcomes) show sustained weight loss (averaging 22.9%) with lifestyle interventions. Additionally, it reduced the risk of progressing to type 2 diabetes by 94% in at-risk individuals.

Possible Side Effects & Warnings

Common Side Effects: Nausea, diarrhea, vomiting, constipation, abdominal pain, heartburn, and fatigue. These are often most pronounced when initiating therapy or increasing the dose.

Severe Side Effects: Potential for severe stomach pain (indicating possible gallbladder issues), severe nausea/vomiting, and signs of low blood sugar (hypoglycemia), particularly if used with insulin or sulfonylureas.

Black Box Warning: Tirzepatide carries a black box warning regarding the potential risk of thyroid C-cell tumors. It is contraindicated in patients with a personal or family history of Medullary Thyroid Carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Disclaimer: This information is for general knowledge and educational purposes only and does not constitute medical advice. Tirzepitide is a  prescription medication that should only be used under the guidance of a licensed healthcare professional. Always follow your prescribed dosage and administration instructions